Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2015-10-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Fe Absorption From Iron Salt in Milk
NCT05642689
Iron Bioavailability From Fortified Food
NCT02993835
Iron Bioavailability of Fortified Oat Drink
NCT01423162
Bioavailability of Iron From Savoury Food Product
NCT02280915
Baby Iron Bioavailability Study
NCT03754543
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The total sample size is 20 enrolled subjects. Patients will be healthy females aged 18-40 years old
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dairy product + Salt 1
Dairy product fortified with enriched Fe-54 salt (1)
Dairy product fortified with enriched Fe-54 salt (1)
2.5mg of Fe per 100g of product
Dairy product + Salt 2
Dairy product fortified with enriched Fe-57 salt (2)
Dairy product fortified with enriched Fe-57 salt (2)
2.5mg of Fe per 100g of product
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dairy product fortified with enriched Fe-54 salt (1)
2.5mg of Fe per 100g of product
Dairy product fortified with enriched Fe-57 salt (2)
2.5mg of Fe per 100g of product
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy, based on the medical screening visit including a blood formula and biochemistry,
* Normal BMI for age (18.5-25.0),
* Weight less than 65 kg,
* Having obtained informed consent prior trial entry.
Exclusion Criteria
* Significant blood losses over the past 6 months,
* Plasma ferritin out of 8-50 ug/L range.
* Any infectious and inflammatory disease in the past four weeks,
* Relevant digestive (intestinal, gastric, hepatic or pancreatic), renal, metabolic disease,
* Known food allergy,
* Pregnancy (anamnesis) and/or lactation,
* History of cancer within the past year,
* Significant weight loss during the last 3 months (5% and more),
* medication or supplement which may impact red cells count, Hb or Ht
* Fe supplementation or perfusion in the last three months,
* Smokers (\>5 cigarettes),
* Have a high alcohol consumption (more than 2 drinks/day),
* Consumption of illicit drugs anamnesis only,
* Subject having a hierarchical link with the Investigator or co-investigators,
* Subject who cannot be expected to comply with treatment or study procedure,
* participating or having participated in another clinical trial during the past month prior to the beginning of this study.
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maurice Beaumont
Role: PRINCIPAL_INVESTIGATOR
Metabolic Unit - Nestec
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Metabolic Unit, Clinical Development Unit, Nestec
Lausanne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15.06.MET
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.